Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection.

ABSTRACT:

Background

In infants, respiratory syncytial virus (RSV) infection occasionally causes severe symptoms requiring respiratory support; however, supportive care is the primary treatment. This study compared the use of respiratory support among infants with RSV infection treated with or without pranlukast.

Methods

This retrospective cohort study included infants aged <10 months with RSV infection who were admitted to three secondary level hospitals in Japan between 2012 and 2019. The infants were divided into two groups depending on whether they were treated with pranlukast. The primary outcome was the receiving respiratory support (high-flow nasal cannula, nasal continuous positive airway pressure, or ventilator). The secondary outcomes were the length of hospital stay, and th

SUBMITTER: Kubota J 

PROVIDER: S-EPMC9140240 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature